Clinicopathological value of the upregulation of cyclin-dependent kinases regulatory subunit 2 in osteosarcoma
Cyclin-dependent kinase subunit 2 (CKS2) is a member of cyclin dependent kinase subfamily and the relationship between CKS2 and osteosarcoma (OS) remains to be further analyzed. 80 OS and 41 non-tumor tissue samples were arranged to perform immunohistochemistry (IHC) to evaluate CKS2 expression betw...
Saved in:
Published in | BMC medical genomics Vol. 15; no. 1; p. 81 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
BioMed Central Ltd
11.04.2022
BioMed Central BMC |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Cyclin-dependent kinase subunit 2 (CKS2) is a member of cyclin dependent kinase subfamily and the relationship between CKS2 and osteosarcoma (OS) remains to be further analyzed.
80 OS and 41 non-tumor tissue samples were arranged to perform immunohistochemistry (IHC) to evaluate CKS2 expression between OS and non-tumor samples. The standard mean deviation (SMD) was calculated based on in-house IHC and tissue microarrays, and exterior high-throughput datasets for further verification of CKS2 expression trend in OS. The effect of CKS2 expression on clinicopathological parameters of OS patients, and single-cell in OS tissues was analyzed through public high-throughput datasets and functional enrichment analysis was conducted for co-expression genes of CKS2 in accordance with weighted correlation network analysis.
A total of 217 OS samples and 87 non-tumor samples (including tissue and cell line) were obtained from in-house IHC, microarrays and exterior high-throughput datasets. The analysis of integrated expression status demonstrated up-regulation of CKS2 in OS (SMD = 1.57, 95%CI [0.27-2.86]) and the significant power of CKS2 expression in distinguishing OS samples from non-tumor samples (AUC = 0.97 95%CI [0.95-0.98]). Clinicopathological analysis of GSE21257 indicated that OS patients with higher CKS2 expression was more likely to suffer OS metastasis. Although Kaplan-Meier curves showed no remarkable difference of overall survival rate between OS patients with high and low-CKS2, CKS2 was found up-regulated in proliferating osteosarcoma cells. Co-expression genes of CKS2 were mainly assembled in function and pathways such as cell cycle, cell adhesion, and intercellular material transport.
In summary, up-regulation of CKS2 expression in OS tissue was found through multiple technical approaches. In addition, scRNA-seq and co-expression analysis showed that CKS2 may have an impact on important biological process linked with cell cycle, cell adhesion, and intercellular material transport. Present study on CKS2 in OS indicated a promising prospect for CKS2 as a biomarker for OS. |
---|---|
AbstractList | Cyclin-dependent kinase subunit 2 (CKS2) is a member of cyclin dependent kinase subfamily and the relationship between CKS2 and osteosarcoma (OS) remains to be further analyzed. 80 OS and 41 non-tumor tissue samples were arranged to perform immunohistochemistry (IHC) to evaluate CKS2 expression between OS and non-tumor samples. The standard mean deviation (SMD) was calculated based on in-house IHC and tissue microarrays, and exterior high-throughput datasets for further verification of CKS2 expression trend in OS. The effect of CKS2 expression on clinicopathological parameters of OS patients, and single-cell in OS tissues was analyzed through public high-throughput datasets and functional enrichment analysis was conducted for co-expression genes of CKS2 in accordance with weighted correlation network analysis. A total of 217 OS samples and 87 non-tumor samples (including tissue and cell line) were obtained from in-house IHC, microarrays and exterior high-throughput datasets. The analysis of integrated expression status demonstrated up-regulation of CKS2 in OS (SMD = 1.57, 95%CI [0.27-2.86]) and the significant power of CKS2 expression in distinguishing OS samples from non-tumor samples (AUC = 0.97 95%CI [0.95-0.98]). Clinicopathological analysis of GSE21257 indicated that OS patients with higher CKS2 expression was more likely to suffer OS metastasis. Although Kaplan-Meier curves showed no remarkable difference of overall survival rate between OS patients with high and low-CKS2, CKS2 was found up-regulated in proliferating osteosarcoma cells. Co-expression genes of CKS2 were mainly assembled in function and pathways such as cell cycle, cell adhesion, and intercellular material transport. In summary, up-regulation of CKS2 expression in OS tissue was found through multiple technical approaches. In addition, scRNA-seq and co-expression analysis showed that CKS2 may have an impact on important biological process linked with cell cycle, cell adhesion, and intercellular material transport. Present study on CKS2 in OS indicated a promising prospect for CKS2 as a biomarker for OS. Background Cyclin-dependent kinase subunit 2 (CKS2) is a member of cyclin dependent kinase subfamily and the relationship between CKS2 and osteosarcoma (OS) remains to be further analyzed. Methods 80 OS and 41 non-tumor tissue samples were arranged to perform immunohistochemistry (IHC) to evaluate CKS2 expression between OS and non-tumor samples. The standard mean deviation (SMD) was calculated based on in-house IHC and tissue microarrays, and exterior high-throughput datasets for further verification of CKS2 expression trend in OS. The effect of CKS2 expression on clinicopathological parameters of OS patients, and single-cell in OS tissues was analyzed through public high-throughput datasets and functional enrichment analysis was conducted for co-expression genes of CKS2 in accordance with weighted correlation network analysis. Results A total of 217 OS samples and 87 non-tumor samples (including tissue and cell line) were obtained from in-house IHC, microarrays and exterior high-throughput datasets. The analysis of integrated expression status demonstrated up-regulation of CKS2 in OS (SMD = 1.57, 95%CI [0.27–2.86]) and the significant power of CKS2 expression in distinguishing OS samples from non-tumor samples (AUC = 0.97 95%CI [0.95–0.98]). Clinicopathological analysis of GSE21257 indicated that OS patients with higher CKS2 expression was more likely to suffer OS metastasis. Although Kaplan–Meier curves showed no remarkable difference of overall survival rate between OS patients with high and low-CKS2, CKS2 was found up-regulated in proliferating osteosarcoma cells. Co-expression genes of CKS2 were mainly assembled in function and pathways such as cell cycle, cell adhesion, and intercellular material transport. Conclusions In summary, up-regulation of CKS2 expression in OS tissue was found through multiple technical approaches. In addition, scRNA-seq and co-expression analysis showed that CKS2 may have an impact on important biological process linked with cell cycle, cell adhesion, and intercellular material transport. Present study on CKS2 in OS indicated a promising prospect for CKS2 as a biomarker for OS. Abstract Background Cyclin-dependent kinase subunit 2 (CKS2) is a member of cyclin dependent kinase subfamily and the relationship between CKS2 and osteosarcoma (OS) remains to be further analyzed. Methods 80 OS and 41 non-tumor tissue samples were arranged to perform immunohistochemistry (IHC) to evaluate CKS2 expression between OS and non-tumor samples. The standard mean deviation (SMD) was calculated based on in-house IHC and tissue microarrays, and exterior high-throughput datasets for further verification of CKS2 expression trend in OS. The effect of CKS2 expression on clinicopathological parameters of OS patients, and single-cell in OS tissues was analyzed through public high-throughput datasets and functional enrichment analysis was conducted for co-expression genes of CKS2 in accordance with weighted correlation network analysis. Results A total of 217 OS samples and 87 non-tumor samples (including tissue and cell line) were obtained from in-house IHC, microarrays and exterior high-throughput datasets. The analysis of integrated expression status demonstrated up-regulation of CKS2 in OS (SMD = 1.57, 95%CI [0.27–2.86]) and the significant power of CKS2 expression in distinguishing OS samples from non-tumor samples (AUC = 0.97 95%CI [0.95–0.98]). Clinicopathological analysis of GSE21257 indicated that OS patients with higher CKS2 expression was more likely to suffer OS metastasis. Although Kaplan–Meier curves showed no remarkable difference of overall survival rate between OS patients with high and low-CKS2, CKS2 was found up-regulated in proliferating osteosarcoma cells. Co-expression genes of CKS2 were mainly assembled in function and pathways such as cell cycle, cell adhesion, and intercellular material transport. Conclusions In summary, up-regulation of CKS2 expression in OS tissue was found through multiple technical approaches. In addition, scRNA-seq and co-expression analysis showed that CKS2 may have an impact on important biological process linked with cell cycle, cell adhesion, and intercellular material transport. Present study on CKS2 in OS indicated a promising prospect for CKS2 as a biomarker for OS. BACKGROUNDCyclin-dependent kinase subunit 2 (CKS2) is a member of cyclin dependent kinase subfamily and the relationship between CKS2 and osteosarcoma (OS) remains to be further analyzed. METHODS80 OS and 41 non-tumor tissue samples were arranged to perform immunohistochemistry (IHC) to evaluate CKS2 expression between OS and non-tumor samples. The standard mean deviation (SMD) was calculated based on in-house IHC and tissue microarrays, and exterior high-throughput datasets for further verification of CKS2 expression trend in OS. The effect of CKS2 expression on clinicopathological parameters of OS patients, and single-cell in OS tissues was analyzed through public high-throughput datasets and functional enrichment analysis was conducted for co-expression genes of CKS2 in accordance with weighted correlation network analysis. RESULTSA total of 217 OS samples and 87 non-tumor samples (including tissue and cell line) were obtained from in-house IHC, microarrays and exterior high-throughput datasets. The analysis of integrated expression status demonstrated up-regulation of CKS2 in OS (SMD = 1.57, 95%CI [0.27-2.86]) and the significant power of CKS2 expression in distinguishing OS samples from non-tumor samples (AUC = 0.97 95%CI [0.95-0.98]). Clinicopathological analysis of GSE21257 indicated that OS patients with higher CKS2 expression was more likely to suffer OS metastasis. Although Kaplan-Meier curves showed no remarkable difference of overall survival rate between OS patients with high and low-CKS2, CKS2 was found up-regulated in proliferating osteosarcoma cells. Co-expression genes of CKS2 were mainly assembled in function and pathways such as cell cycle, cell adhesion, and intercellular material transport. CONCLUSIONSIn summary, up-regulation of CKS2 expression in OS tissue was found through multiple technical approaches. In addition, scRNA-seq and co-expression analysis showed that CKS2 may have an impact on important biological process linked with cell cycle, cell adhesion, and intercellular material transport. Present study on CKS2 in OS indicated a promising prospect for CKS2 as a biomarker for OS. Cyclin-dependent kinase subunit 2 (CKS2) is a member of cyclin dependent kinase subfamily and the relationship between CKS2 and osteosarcoma (OS) remains to be further analyzed. 80 OS and 41 non-tumor tissue samples were arranged to perform immunohistochemistry (IHC) to evaluate CKS2 expression between OS and non-tumor samples. The standard mean deviation (SMD) was calculated based on in-house IHC and tissue microarrays, and exterior high-throughput datasets for further verification of CKS2 expression trend in OS. The effect of CKS2 expression on clinicopathological parameters of OS patients, and single-cell in OS tissues was analyzed through public high-throughput datasets and functional enrichment analysis was conducted for co-expression genes of CKS2 in accordance with weighted correlation network analysis. A total of 217 OS samples and 87 non-tumor samples (including tissue and cell line) were obtained from in-house IHC, microarrays and exterior high-throughput datasets. The analysis of integrated expression status demonstrated up-regulation of CKS2 in OS (SMD = 1.57, 95%CI [0.27-2.86]) and the significant power of CKS2 expression in distinguishing OS samples from non-tumor samples (AUC = 0.97 95%CI [0.95-0.98]). Clinicopathological analysis of GSE21257 indicated that OS patients with higher CKS2 expression was more likely to suffer OS metastasis. Although Kaplan-Meier curves showed no remarkable difference of overall survival rate between OS patients with high and low-CKS2, CKS2 was found up-regulated in proliferating osteosarcoma cells. Co-expression genes of CKS2 were mainly assembled in function and pathways such as cell cycle, cell adhesion, and intercellular material transport. In summary, up-regulation of CKS2 expression in OS tissue was found through multiple technical approaches. In addition, scRNA-seq and co-expression analysis showed that CKS2 may have an impact on important biological process linked with cell cycle, cell adhesion, and intercellular material transport. Present study on CKS2 in OS indicated a promising prospect for CKS2 as a biomarker for OS. |
ArticleNumber | 81 |
Audience | Academic |
Author | Mao, Rongjun Huang, Yingxin Xu, Yuanyuan Mo, Chaohua Xie, Le Chen, Zengwei Wu, Yanxing Zeng, Min Peng, Huizhi Ma, Jie |
Author_xml | – sequence: 1 givenname: Chaohua surname: Mo fullname: Mo, Chaohua organization: Department of Pathology, Foshan Hospital of Traditional Chinese Medicine, Guangzhou University of Chinese Medicine, Foshan, 528300, Guangdong, China – sequence: 2 givenname: Yanxing surname: Wu fullname: Wu, Yanxing organization: Department of Pathology, Foshan Hospital of Traditional Chinese Medicine, Guangzhou University of Chinese Medicine, Foshan, 528300, Guangdong, China – sequence: 3 givenname: Jie surname: Ma fullname: Ma, Jie organization: Department of Medical Oncology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, China – sequence: 4 givenname: Le surname: Xie fullname: Xie, Le organization: Department of Pathology, Foshan Hospital of Traditional Chinese Medicine, Guangzhou University of Chinese Medicine, Foshan, 528300, Guangdong, China – sequence: 5 givenname: Yingxin surname: Huang fullname: Huang, Yingxin organization: Department of Pathology, Foshan Hospital of Traditional Chinese Medicine, Guangzhou University of Chinese Medicine, Foshan, 528300, Guangdong, China – sequence: 6 givenname: Yuanyuan surname: Xu fullname: Xu, Yuanyuan organization: Department of Pathology, Foshan Hospital of Traditional Chinese Medicine, Guangzhou University of Chinese Medicine, Foshan, 528300, Guangdong, China – sequence: 7 givenname: Huizhi surname: Peng fullname: Peng, Huizhi organization: Department of Pathology, Foshan Hospital of Traditional Chinese Medicine, Guangzhou University of Chinese Medicine, Foshan, 528300, Guangdong, China – sequence: 8 givenname: Zengwei surname: Chen fullname: Chen, Zengwei organization: Department of Pathology, Foshan Hospital of Traditional Chinese Medicine, Guangzhou University of Chinese Medicine, Foshan, 528300, Guangdong, China – sequence: 9 givenname: Min surname: Zeng fullname: Zeng, Min organization: Department of Pathology, Foshan Hospital of Traditional Chinese Medicine, Guangzhou University of Chinese Medicine, Foshan, 528300, Guangdong, China – sequence: 10 givenname: Rongjun surname: Mao fullname: Mao, Rongjun email: maorj@fshtcm.com.cn organization: Department of Pathology, Foshan Hospital of Traditional Chinese Medicine, Guangzhou University of Chinese Medicine, Foshan, 528300, Guangdong, China. maorj@fshtcm.com.cn |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/35410253$$D View this record in MEDLINE/PubMed |
BookMark | eNptUstqGzEUHUpKk7j9gS7KQDfpYlJJo-emEEwfhkChj7WQNXfGcseSK2lC_feVYzeNS9FC4uqcc7nnnsvqzAcPVfUSo2uMJX-bMFEENYiQBmHS0kY-qS6wYKyRQtGzR-_z6jKlNUIcMYWfVectoxgR1l5Ufj4672zYmrwKYxicNWN9Z8YJ6tDXeQX1tI0wTKPJLvh9ze5soTQdbMF34HP9w3mTINVHWIi7Ok3Lybtck9oVTsoQkok2bMzz6mlvxgQvjves-v7h_bf5p-b288fF_Oa2sUyJ3PRcCUZgSTiSfYusIkCxwMpapbiRBknVAoMO2l5I2lEqjVoC7imH1hgs21m1OOh2waz1NrqNiTsdjNP3hRAHbWJ2dgTNRceVbRGjoqdMgJSWdkaVfqbrGcdF691BazstN9DZMnM044no6Y93Kz2EO60QopyoInB1FIjh5wQp641LFsbReAhT0oRTxSTHZSGz6vU_0HWYoi9WFRTDigsh0V_UYMoAzveh9LV7UX0jECKICbT34Po_qHI62JSNe-hdqZ8Q3pwQCibDrzyYKSW9-PrlFEsOWBtDShH6Bz8w0vt06kM6dUmnvk-n3pNePXbygfInju1vsLzg9g |
CitedBy_id | crossref_primary_10_1002_ctd2_202 |
Cites_doi | 10.1007/978-1-4419-0284-9_20 10.3390/cells10010172 10.1038/nature19076 10.1186/s12859-019-3256-9 10.1111/jvim.12603 10.1186/s41065-018-0061-9 10.1038/s41598-018-23672-0 10.1053/sonc.2002.37263 10.1002/jcp.28065 10.1016/j.bone.2019.115070 10.1007/s40272-014-0095-z 10.4103/0019-5413.132497 10.1089/omi.2011.0118 10.1111/j.1478-3231.2009.02106.x 10.1016/j.ejca.2019.07.018 10.1155/2021/6885897 10.1016/j.gene.2017.11.028 10.1016/S0960-9822(96)00741-5 10.1007/s12105-020-01139-x 10.1186/1471-2105-9-559 10.1177/147323001103900222 10.1093/bioinformatics/bts034 10.1093/bioinformatics/btq064 10.1093/annonc/mdq276 10.1158/1078-0432.CCR-10-1300 10.1016/j.phrs.2018.11.035 10.3892/ol.2013.1456 10.1186/gb4184 10.3892/mco.2015.501 10.1093/nar/gkaa407 10.1186/s13018-021-02647-4 10.1158/0008-5472.CAN-05-4000 10.3892/or.2014.3062 10.3390/cells9040976 10.1111/cas.13336 10.1016/j.bbadis.2018.02.004 10.1007/978-1-4419-0284-9_12 10.3389/pore.2021.609472 10.1016/j.humpath.2014.12.006 |
ContentType | Journal Article |
Copyright | 2022. The Author(s). COPYRIGHT 2022 BioMed Central Ltd. 2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. The Author(s) 2022 |
Copyright_xml | – notice: 2022. The Author(s). – notice: COPYRIGHT 2022 BioMed Central Ltd. – notice: 2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: The Author(s) 2022 |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION ISR 3V. 7X7 7XB 88E 8AO 8FD 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FR3 FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M1P M7P P64 PIMPY PQEST PQQKQ PQUKI PRINS RC3 7X8 5PM DOA |
DOI | 10.1186/s12920-022-01234-8 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Science in Context ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Technology Research Database ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One Community College ProQuest Central Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences Health & Medical Collection (Alumni Edition) Medical Database Biological Science Database Biotechnology and BioEngineering Abstracts Publicly Available Content Database ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China Genetics Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Publicly Available Content Database ProQuest Central Student Technology Research Database ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central China ProQuest Central Genetics Abstracts Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Biological Science Collection ProQuest Medical Library (Alumni) ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Engineering Research Database ProQuest One Academic ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | Publicly Available Content Database CrossRef MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ: Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Databases url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1755-8794 |
EndPage | 81 |
ExternalDocumentID | oai_doaj_org_article_67d69c30547f457e88c4da9417adf561 A700205708 10_1186_s12920_022_01234_8 35410253 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GeographicLocations | China United States--US |
GeographicLocations_xml | – name: China – name: United States--US |
GrantInformation_xml | – fundername: ; grantid: 1920001001538; 1920001001538; 1920001001538; 1920001001538; 1920001001538; 1920001001538; 1920001001538; 1920001001538; 1920001001538 |
GroupedDBID | --- -A0 0R~ 23N 2WC 3V. 53G 5GY 5VS 6J9 7X7 88E 8AO 8FE 8FH 8FI 8FJ AAFWJ AAJSJ ABDBF ABUWG ACGFO ACGFS ACIHN ACMJI ACPRK ACRMQ ADBBV ADINQ ADUKV AEAQA AENEX AFKRA AFPKN AHBYD AHMBA AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BBNVY BCNDV BENPR BFQNJ BHPHI BMC BPHCQ BVXVI C24 C6C CCPQU CGR CS3 CUY CVF DIK DU5 E3Z EBD EBLON EBS ECM EIF EMOBN ESX F5P FYUFA GROUPED_DOAJ GX1 HCIFZ HMCUK HYE IAO IHR INH INR ISR ITC KQ8 LK8 M1P M48 M7P M~E NPM O5R O5S OK1 P2P PGMZT PIMPY PQQKQ PROAC PSQYO RBZ RNS ROL RPM RSV SBL SOJ SV3 TR2 TUS UKHRP W2D ~8M AAYXX CITATION AFGXO ABVAZ AFNRJ 7XB 8FD 8FK AZQEC DWQXO FR3 GNUQQ K9. P64 PQEST PQUKI PRINS RC3 7X8 5PM |
ID | FETCH-LOGICAL-c597t-f69752eb2608f30c92e41719cc996a8a0893e5ede3f784d448a9be1f46e3aa183 |
IEDL.DBID | RPM |
ISSN | 1755-8794 |
IngestDate | Tue Oct 22 15:16:39 EDT 2024 Tue Sep 17 21:18:19 EDT 2024 Sat Aug 17 01:57:34 EDT 2024 Thu Oct 10 17:15:34 EDT 2024 Thu Feb 22 23:32:31 EST 2024 Fri Feb 02 04:10:28 EST 2024 Thu Aug 01 19:38:31 EDT 2024 Wed Sep 25 14:09:45 EDT 2024 Sat Sep 28 08:19:43 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Language | English |
License | 2022. The Author(s). Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c597t-f69752eb2608f30c92e41719cc996a8a0893e5ede3f784d448a9be1f46e3aa183 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9004629/ |
PMID | 35410253 |
PQID | 2651967780 |
PQPubID | 55237 |
PageCount | 1 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_67d69c30547f457e88c4da9417adf561 pubmedcentral_primary_oai_pubmedcentral_nih_gov_9004629 proquest_miscellaneous_2649586125 proquest_journals_2651967780 gale_infotracmisc_A700205708 gale_infotracacademiconefile_A700205708 gale_incontextgauss_ISR_A700205708 crossref_primary_10_1186_s12920_022_01234_8 pubmed_primary_35410253 |
PublicationCentury | 2000 |
PublicationDate | 2022-04-11 |
PublicationDateYYYYMMDD | 2022-04-11 |
PublicationDate_xml | – month: 04 year: 2022 text: 2022-04-11 day: 11 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: London |
PublicationTitle | BMC medical genomics |
PublicationTitleAlternate | BMC Med Genomics |
PublicationYear | 2022 |
Publisher | BioMed Central Ltd BioMed Central BMC |
Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central – name: BMC |
References | TS Goh (1234_CR28) 2019; 234 D Vella (1234_CR43) 2018; 8 J Folkman (1234_CR39) 2002; 29 Y Kita (1234_CR14) 2014; 31 M Yu (1234_CR17) 2013; 6 G Yu (1234_CR25) 2012; 16 F Tanaka (1234_CR15) 2011; 39 X Xiao (1234_CR5) 2014; 16 A Smrke (1234_CR31) 2021; 10 R Roskoski Jr (1234_CR6) 2019; 139 K Behzatoglu (1234_CR32) 2021; 27 SK Miryala (1234_CR42) 2018; 642 Y Pan (1234_CR41) 2018; 155 D Shen (1234_CR13) 2010; 30 J Leek (1234_CR21) 2012; 28 M Malumbres (1234_CR7) 2014; 15 J Ritter (1234_CR2) 2010; 21 K Kawakami (1234_CR19) 2006; 16 I Zambo (1234_CR1) 2014; 50 P Cai (1234_CR30) 2021; 2021 N Wadhwa (1234_CR27) 2014; 48 X Chen (1234_CR29) 2021; 16 Y Zhou (1234_CR8) 2018; 1864 N Jaffe (1234_CR3) 2009; 152 I Corre (1234_CR34) 2020; 9 M Stanbrough (1234_CR45) 2006; 66 B Strilic (1234_CR40) 2016; 536 C Zhang (1234_CR26) 2020; 130 Y Jung (1234_CR16) 2011; 17 M Punzalan (1234_CR33) 2009; 152 AL Limbach (1234_CR9) 2020; 14 JJ Pines (1234_CR11) 1996; 6 H You (1234_CR12) 2015; 3 G Yu (1234_CR24) 2010; 26 R Chen (1234_CR20) 2011; 39 B Arneth (1234_CR37) 2019; 56 J Zhao (1234_CR44) 2019; 20 A Righi (1234_CR10) 2015; 46 D Notterman (1234_CR18) 2001; 61 T Li (1234_CR22) 2020; 48 P Langfelder (1234_CR23) 2008; 9 A Biazzo (1234_CR4) 2016; 82 KL Wycislo (1234_CR35) 2015; 29 A Le Cesne (1234_CR36) 2019; 119 N Maishi (1234_CR38) 2017; 108 |
References_xml | – volume: 39 start-page: 361 issue: 2 year: 2011 ident: 1234_CR15 publication-title: Int J Oncol contributor: fullname: F Tanaka – volume: 152 start-page: 367 year: 2009 ident: 1234_CR33 publication-title: Cancer Treat Res doi: 10.1007/978-1-4419-0284-9_20 contributor: fullname: M Punzalan – volume: 10 start-page: 172 issue: 1 year: 2021 ident: 1234_CR31 publication-title: Cells doi: 10.3390/cells10010172 contributor: fullname: A Smrke – volume: 56 start-page: 15 issue: 1 year: 2019 ident: 1234_CR37 publication-title: Med (Kaunas, Lith) contributor: fullname: B Arneth – volume: 536 start-page: 215 issue: 7615 year: 2016 ident: 1234_CR40 publication-title: Nature doi: 10.1038/nature19076 contributor: fullname: B Strilic – volume: 50 start-page: 64 issue: 2 year: 2014 ident: 1234_CR1 publication-title: Ceskoslov Patol contributor: fullname: I Zambo – volume: 20 start-page: 682 issue: Suppl 25 year: 2019 ident: 1234_CR44 publication-title: BMC Bioinform doi: 10.1186/s12859-019-3256-9 contributor: fullname: J Zhao – volume: 29 start-page: 759 issue: 3 year: 2015 ident: 1234_CR35 publication-title: J Vet Intern Med doi: 10.1111/jvim.12603 contributor: fullname: KL Wycislo – volume: 155 start-page: 21 year: 2018 ident: 1234_CR41 publication-title: Hereditas doi: 10.1186/s41065-018-0061-9 contributor: fullname: Y Pan – volume: 8 start-page: 5499 issue: 1 year: 2018 ident: 1234_CR43 publication-title: Sci Rep doi: 10.1038/s41598-018-23672-0 contributor: fullname: D Vella – volume: 29 start-page: 15 issue: 6 Suppl 16 year: 2002 ident: 1234_CR39 publication-title: Semin Oncol doi: 10.1053/sonc.2002.37263 contributor: fullname: J Folkman – volume: 234 start-page: 13851 issue: 8 year: 2019 ident: 1234_CR28 publication-title: J Cell Physiol doi: 10.1002/jcp.28065 contributor: fullname: TS Goh – volume: 130 start-page: 115070 year: 2020 ident: 1234_CR26 publication-title: Bone doi: 10.1016/j.bone.2019.115070 contributor: fullname: C Zhang – volume: 16 start-page: 503 issue: 6 year: 2014 ident: 1234_CR5 publication-title: Pediatr Drugs doi: 10.1007/s40272-014-0095-z contributor: fullname: X Xiao – volume: 61 start-page: 3124 issue: 7 year: 2001 ident: 1234_CR18 publication-title: Cancer Res contributor: fullname: D Notterman – volume: 48 start-page: 247 issue: 3 year: 2014 ident: 1234_CR27 publication-title: Indian J Orthop doi: 10.4103/0019-5413.132497 contributor: fullname: N Wadhwa – volume: 16 start-page: 284 issue: 5 year: 2012 ident: 1234_CR25 publication-title: OMICS doi: 10.1089/omi.2011.0118 contributor: fullname: G Yu – volume: 30 start-page: 119 issue: 1 year: 2010 ident: 1234_CR13 publication-title: Liver Int doi: 10.1111/j.1478-3231.2009.02106.x contributor: fullname: D Shen – volume: 119 start-page: 151 year: 2019 ident: 1234_CR36 publication-title: Eur J Cancer (Oxf Engl 1990) doi: 10.1016/j.ejca.2019.07.018 contributor: fullname: A Le Cesne – volume: 2021 start-page: 6885897 year: 2021 ident: 1234_CR30 publication-title: Biomed Res Int doi: 10.1155/2021/6885897 contributor: fullname: P Cai – volume: 642 start-page: 84 year: 2018 ident: 1234_CR42 publication-title: Gene doi: 10.1016/j.gene.2017.11.028 contributor: fullname: SK Miryala – volume: 6 start-page: 1399 issue: 11 year: 1996 ident: 1234_CR11 publication-title: Curr Biol doi: 10.1016/S0960-9822(96)00741-5 contributor: fullname: JJ Pines – volume: 14 start-page: 889 issue: 4 year: 2020 ident: 1234_CR9 publication-title: Head Neck Pathol doi: 10.1007/s12105-020-01139-x contributor: fullname: AL Limbach – volume: 9 start-page: 559 year: 2008 ident: 1234_CR23 publication-title: BMC Bioinform doi: 10.1186/1471-2105-9-559 contributor: fullname: P Langfelder – volume: 82 start-page: 690 issue: 4 year: 2016 ident: 1234_CR4 publication-title: Acta Orthop Belg contributor: fullname: A Biazzo – volume: 39 start-page: 533 issue: 2 year: 2011 ident: 1234_CR20 publication-title: J Int Med Res doi: 10.1177/147323001103900222 contributor: fullname: R Chen – volume: 28 start-page: 882 issue: 6 year: 2012 ident: 1234_CR21 publication-title: Bioinformatics doi: 10.1093/bioinformatics/bts034 contributor: fullname: J Leek – volume: 26 start-page: 976 issue: 7 year: 2010 ident: 1234_CR24 publication-title: Bioinformatics doi: 10.1093/bioinformatics/btq064 contributor: fullname: G Yu – volume: 21 start-page: vii320 year: 2010 ident: 1234_CR2 publication-title: Ann Oncol doi: 10.1093/annonc/mdq276 contributor: fullname: J Ritter – volume: 17 start-page: 700 issue: 4 year: 2011 ident: 1234_CR16 publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-10-1300 contributor: fullname: Y Jung – volume: 139 start-page: 471 year: 2019 ident: 1234_CR6 publication-title: Pharmacol Res doi: 10.1016/j.phrs.2018.11.035 contributor: fullname: R Roskoski Jr – volume: 6 start-page: 777 issue: 3 year: 2013 ident: 1234_CR17 publication-title: Oncol Lett doi: 10.3892/ol.2013.1456 contributor: fullname: M Yu – volume: 15 start-page: 122 issue: 6 year: 2014 ident: 1234_CR7 publication-title: Genome Biol doi: 10.1186/gb4184 contributor: fullname: M Malumbres – volume: 3 start-page: 459 issue: 3 year: 2015 ident: 1234_CR12 publication-title: Mol Clin Oncol doi: 10.3892/mco.2015.501 contributor: fullname: H You – volume: 48 start-page: W509 year: 2020 ident: 1234_CR22 publication-title: Nucleic Acids Res doi: 10.1093/nar/gkaa407 contributor: fullname: T Li – volume: 16 start-page: 523 issue: 1 year: 2021 ident: 1234_CR29 publication-title: J Orthop Surg Res doi: 10.1186/s13018-021-02647-4 contributor: fullname: X Chen – volume: 66 start-page: 2815 issue: 5 year: 2006 ident: 1234_CR45 publication-title: Can Res doi: 10.1158/0008-5472.CAN-05-4000 contributor: fullname: M Stanbrough – volume: 31 start-page: 1986 issue: 5 year: 2014 ident: 1234_CR14 publication-title: Oncol Rep doi: 10.3892/or.2014.3062 contributor: fullname: Y Kita – volume: 16 start-page: 521 issue: 3 year: 2006 ident: 1234_CR19 publication-title: Oncol Rep contributor: fullname: K Kawakami – volume: 9 start-page: 976 issue: 4 year: 2020 ident: 1234_CR34 publication-title: Cells doi: 10.3390/cells9040976 contributor: fullname: I Corre – volume: 108 start-page: 1921 issue: 10 year: 2017 ident: 1234_CR38 publication-title: Cancer Sci doi: 10.1111/cas.13336 contributor: fullname: N Maishi – volume: 1864 start-page: 1573 issue: 5 Pt A year: 2018 ident: 1234_CR8 publication-title: Biochim Biophys Acta Mol Basis Dis doi: 10.1016/j.bbadis.2018.02.004 contributor: fullname: Y Zhou – volume: 152 start-page: 239 year: 2009 ident: 1234_CR3 publication-title: Pediatr Adolesc Osteosarcoma doi: 10.1007/978-1-4419-0284-9_12 contributor: fullname: N Jaffe – volume: 27 start-page: 609472 year: 2021 ident: 1234_CR32 publication-title: Pathol Oncol Res doi: 10.3389/pore.2021.609472 contributor: fullname: K Behzatoglu – volume: 46 start-page: 549 issue: 4 year: 2015 ident: 1234_CR10 publication-title: Hum Pathol doi: 10.1016/j.humpath.2014.12.006 contributor: fullname: A Righi |
SSID | ssj0060591 |
Score | 2.3444324 |
Snippet | Cyclin-dependent kinase subunit 2 (CKS2) is a member of cyclin dependent kinase subfamily and the relationship between CKS2 and osteosarcoma (OS) remains to be... Abstract Background Cyclin-dependent kinase subunit 2 (CKS2) is a member of cyclin dependent kinase subfamily and the relationship between CKS2 and... Background Cyclin-dependent kinase subunit 2 (CKS2) is a member of cyclin dependent kinase subfamily and the relationship between CKS2 and osteosarcoma (OS)... BACKGROUNDCyclin-dependent kinase subunit 2 (CKS2) is a member of cyclin dependent kinase subfamily and the relationship between CKS2 and osteosarcoma (OS)... |
SourceID | doaj pubmedcentral proquest gale crossref pubmed |
SourceType | Open Website Open Access Repository Aggregation Database Index Database |
StartPage | 81 |
SubjectTerms | Alcohol Antigens Bone cancer Bone Neoplasms - genetics Bone surgery CDC2-CDC28 Kinases - genetics CDC2-CDC28 Kinases - metabolism Cell adhesion Cell cycle Cell Cycle Proteins - genetics Cell growth Cell Line, Tumor Cell Proliferation - genetics Chemotherapy Cyclin-dependent kinase Cyclin-dependent kinases Cyclins Datasets Gene expression Gene Expression Regulation, Neoplastic Gene set enrichment analysis Genetic aspects Health aspects Humans Immunohistochemistry Kinases Measurement Medical prognosis Metastases Metastasis Mutation Osteosarcoma Osteosarcoma - genetics Osteosarcoma cells Pathology Patient outcomes Patients Phosphotransferases Prognosis Proteins Radiation therapy Sarcoma Tumors Up-Regulation |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3Ni9UwEA-yB_EifltdJYrgQcI2bT6Pq7iswnpQF_YWkjTRh9gur6-H_e-d6cfjFQ9evDZT2s5H8hs68xtC3gQvopHBMKWSZSLxmtnKSGYqy4M3tdcRu5EvvqjzS_H5Sl4djPrCmrCJHnhS3InSjbIRvFLoLKROxkTReCu49k2Wc-LD5ZJMTXswYHTLlxYZo056jkOZGFauI4YQzKyOoZGt_-89-eBQWhdMHpxAZ_fI3Rk60tPple-TW6l9QG5fzD_HH5J24vjscMjwsqVRJPNOtMsUgB4drrfT6HkwBl6LN9gYyZZBuDv6a9PCqdbTWazb3tB-CAOEPa3oBu4Bn-h6iI3ut39ELs8-fv9wzuZxCixC1rBjWVktK8ikVWlyXUZbJdAitzFCzuONLwG6JJmaVGdtRAN5m7ch8SxUqr2H0H9MjtquTU8JDXUyTTBV9twCImggKUFsEZHpJ_gcCvJu0a67nlgz3JhtGOUmWziwhRtt4UxB3qMB9pLIeD1eAD9wsx-4f_lBQV6j-RxyWrRYNPPDD33vPn376k41gmKpS3jS21kod2DI6OceBPgqpMFaSR6vJCHo4np58RI3B33vKgVwGAn5yoK82i_jnVjI1qZuQBnISA3CyoI8mZxq_921FAD3ZF0QvXK3lWLWK-3m50gJbscmY_vsf2jyOblTjZEiGOfH5Gi3HdILQF678HIMsj8wLyq2 priority: 102 providerName: Directory of Open Access Journals – databaseName: ProQuest Central dbid: BENPR link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3da9UwFA-6gfgifludEkXwQcJu2jRNnmSTjSlsyHSwt5Ck6XYRm-vt7cP-e89p0-uK4GtzSpuej_xOk_M7hLx3VnhVOsWkDJqJwAumc1UylWvurCps5bEa-fRMnlyIr5flZfrh1qVjlVNMHAJ1HT3-I9_PJWANZDtbfFr9Ztg1CndXUwuNu2Q35wK3aXcPj86-nU-xGLC65lOpjJL7HcfmTAxPsCOWEEzNlqOBtf_f2HxrcZofnLy1Eh0_JA8ShKQHo84fkTuhfUzunaZN8iekHbk-IzYbnkIbRVLvQGNDAfDRfrUeW9CDUvCav8ECSTY1xN3Qn8sWVreOJrG4vqFd73pwf5rTJdwDthE78JH4yz4lF8dHPz6fsNRWgXnIHjaskboqc8io5UI1xcLrPAhece095D5W2QVAmFCGOhRNpUQN-ZvVLvBGyFBYCyHgGdlpYxteEOqKoGqn8sZyDcighuQEMYZHxh9nG5eRj9PXNauRPcMMWYeSZtSFAV2YQRdGZeQQFbCVRObr4UJcX5nkSEZWtdQeopSoGlFWQSkvaqthBrZuAAxm5B2qzyC3RYuHZ65s33Xmy_dzc1AhOC6rBTzpQxJqIijS21SLALNCOqyZ5N5MEpzPz4cnKzHJ-Tvz11Qz8nY7jHfigbY2xB5lIDNVCC8z8nw0qu28i1IA7CuLjFQzc5t9mPlIu7weqMH1UGysX_7_tV6R-_ngA4Jxvkd2Nus-vAZstXFvkgP9AaMKJCQ priority: 102 providerName: ProQuest – databaseName: Scholars Portal Open Access Journals dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9QwELZKkRCXijeBggxC4oAMeTh-HBAqiKogLQdgpd4sx7HLCpqUzUZi_z0zTrJqRA9c48nDnoe_UTzfEPKistypslJMCK8Z91nBdK5KpnKdVVYVVjqsRl58ESdL_vm0PN0jU7ujcQG7K1M77Ce1XP96_ef39h04_Nvo8Eq86TJsucTwXDoiBM7UNXI95wVHi1_w3V8FQO6xgx7smPAxYIhTEc2Vz5htVJHP_9-ofWnbmh-pvLRHHd8iByO4pEeDNdwme765Q24sxt_nd0kzsIC22IZ4CnoU6b49bQMFKEj7i_XQnB7UhdfcFksn2dQqd0N_rhrY9zo6irXrLe36qofAQHO6gnvAatoOvKc9t_fI8vjj9w8nbGy4wBzkFRsWhJZlDrm2SFUoUqdzzzOZaecgK7LKpgBufOlrXwSpeA2ZndWVzwIXvrAWgsN9st-0jX9IaFV4VVcqDzbTgBlqSFsQfTjkAqpsqBLyalpdczHwapiYjyhhBl0Y0IWJujAqIe9RATtJ5MSOF9r1mRldzAhZC-0gfnEZeCm9Uo7XVsMMbB0AJibkOarPIOtFg8dqzmzfdebTt6_mSCJsLmUKb3o5CoUWFOnsWKUAs0KirJnk4UwS3NLNhycrMZNVm1wAYEbKvjQhz3bDeCcedWt826MM5KwKgWdCHgxGtZt3UXIAhGWREDkzt9nCzEea1Y9IGq5jGbJ-9D-L8JjczKMncJZlh2R_s-79E8Bem-ppdKi_Az8pwA priority: 102 providerName: Scholars Portal |
Title | Clinicopathological value of the upregulation of cyclin-dependent kinases regulatory subunit 2 in osteosarcoma |
URI | https://www.ncbi.nlm.nih.gov/pubmed/35410253 https://www.proquest.com/docview/2651967780 https://search.proquest.com/docview/2649586125 https://pubmed.ncbi.nlm.nih.gov/PMC9004629 https://doaj.org/article/67d69c30547f457e88c4da9417adf561 |
Volume | 15 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Na9swFBdtB2OXse9564I2BjsMN_6QLemYlpYukFLaFXITkix3YYsd4vjQ_37vyXao2W0XB6wnHPl9_V7yPgj5ajSzIjMizHMnQ-biNJSJyEKRyNhokWpusRp5cZVf3rH5MlsekGyohfFJ-9asTqo_65Nq9cvnVm7WdjrkiU2vF2fSl1TK6SE55Gk6hOid-QV4LuOhOkbk0ybGeUwhJq0jfGAhTuhLMwaONUtHzsj37P_XMj9yTeO0yUd-6OIFed4DSDrrvuhLcuCqV-Tpov-L_DWpuk6fNY4aHgwbxZbejtYlBbhH2822G0APLMF79gHLI8NhHO6O_l5V4Nsa2pPV2wfatKYF5acJXcEekIy6AQ2p1_oNubs4_3l2GfZDFUILscMuLHPJswTi6TwSZRpZmTgW81haC5GPFjoCAOMyV7i05IIVEL1paVxcstylWoMBeEuOqrpy7wk1qROFEUmpYwm4oIDQBBGGxX4_RpcmIN-Ht6s2Xe8M5WMOkauOLQrYojxblAjIKTJgT4l9r_2Nenuveu6rnBe5tGCjGC9Zxp0QlhVawgl0UQIUDMgXZJ_CzhYVps7c67Zp1I_bGzXjCI0zHsGTvvVEZQ2MtLqvRIBTYTOsEeXxiBJUz46XBylRveo3KskBFGNbviggn_fLuBPT2SpXt0gDcalAcBmQd51Q7c89yGZA-EjcRi9mvAJ64huD93rx4b93fiTPEq8pLIzjY3K027buE4CunZmAqi35hDyZzea3c_g8Pb-6vpn4nzDgumBi4tXwL2mhMXY |
link.rule.ids | 230,315,733,786,790,870,891,2115,12083,21416,24346,27955,27956,31752,31753,33777,33778,43343,43838,53825,53827 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagSMAF8SyBAgYhcUBW14njxwkVRLWFbg_QSnuzHMcpK0SybDaH_ntmEmdphMQ1nmjXmYe_SWa-IeRt4YTXeaGZlMEwEXjGTKpzplPDC6czpzx2Iy_O5PxCfFnmy_jCrY1llWNM7AN12Xh8R36YSsAayHY2-7D-zXBqFH5djSM0bpJbIssE2rla7hIuQOqGj40yWh62HEczMaxfRyQhmJ4cRj1n_7-R-drRNC2bvHYOHd8n9yKApEeDxh-QG6F-SG4v4ifyR6QemD4bHDU8BjaKlN6BNhUFuEe79WYYQA8qwWv-Ctsj2TgOd0t_rmo421oaxZrNFW27ogPnpyldwT1gGU0LHtL8co_JxfHn809zFocqMA-5w5ZV0qg8hXxaznSVzbxJg-CKG-8h83HazQDAhDyUIauUFiVkb84UgVdChsw5CABPyF7d1OEpoUUWdFnotHLcAC4oITVBhOGR76dwVZGQ9-PTteuBO8P2OYeWdtCFBV3YXhdWJ-QjKmAnibzX_YVmc2mjG1mpSmk8xCihKpGroLUXpTOwA1dWAAUT8gbVZ5HZosbSmUvXta09-f7NHimExrmawS-9i0JVA4r0LnYiwK6QDGsieTCRBNfz0-XRSmx0_db-NdSEvN4t451YzlaHpkMZyEs1gsuE7A9Gtdt3lgsAfXmWEDUxt8mDma7Uqx89MbjpW43Ns___rVfkzvx8cWpPT86-Pid3094fBOP8gOxtN114AShrW7zsXekPmFslqw |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELagSBUX3o-UAgEhcUDe3SSOH8dSWLXAVhVQqeJi2Y5TVu0mq83mUH49M3msNnDrNR4rmsx45htl_A0h76xhTqZWUs69osxHCVWxTKmMVWSNTIxweBt5dsKPztiX8_R8a9RX07Tv7HxUXC1Gxfx301u5XLhx3yc2Pp0dquZKpRovs3x8m9yBMxuLvlBvgzCAdBX1d2QkH1cRTmWi2LqOIIJRnNOXpAzSa5oMUlLD3P9_fN5KUMPmya1sNL1PfvV6tE0ol6N6bUfuzz8UjzdS9AG512HU8KAVeUhu-eIR2Z11f-Efk6IlEy1xmnEfO0NkDfdhmYeAKMN6uWpn3IPV8Zm7xhuYtJ-4uw4v5wWkzyrsxMrVdVjVtob4EsbhHPaA85UVHMJyYZ6Qs-nnn4dHtJvbQB2UJ2uacyXSGEp2PpF5MnEq9iwSkXIOiisjzQQwkk995pNcSJZBgWiU9VHOuE-MgRjzlOwUZeGfk9AmXmZWxrmJFECPDKofBDEOKYWsyW1APvSm08uWnkM3ZY3kurW5BpvrxuZaBuQjWncjidTazYNydaG77665yLhyEAaZyFkqvJSOZUaBBibLAW0G5C36hkbyjAK7cy5MXVX6-Md3fSAQfadiAm963wnlJXiJM91lB9AK-bYGkvsDSTjdbrjcu6DuokulYw64G5n_JgF5s1nGndgxV_iyRhkofSXi14A8az12o3fv-AERA18efJjhCnhowz3eeeTejXe-Jrunn6b62_HJ1xfkbtycSEajaJ_srFe1fwkQb21fNYf5L8DnUA4 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Clinicopathological+value+of+the+upregulation+of+cyclin-dependent+kinases+regulatory+subunit+2+in+osteosarcoma&rft.jtitle=BMC+medical+genomics&rft.au=Mo%2C+Chaohua&rft.au=Wu%2C+Yanxing&rft.au=Ma%2C+Jie&rft.au=Xie%2C+Le&rft.date=2022-04-11&rft.pub=BioMed+Central+Ltd&rft.issn=1755-8794&rft.eissn=1755-8794&rft.volume=15&rft.issue=1&rft_id=info:doi/10.1186%2Fs12920-022-01234-8&rft.externalDBID=ISR&rft.externalDocID=A700205708 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1755-8794&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1755-8794&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1755-8794&client=summon |